Tango Therapeutics, Inc. (TNGX)

SEC filing

Tango Therapeutics, Inc.

TNGX · CIK 1819133

4 · Sep 3, 2026 · President, R&D Crystal Adam sold 27K shares at $22.37/share ($603.9K); exercised options for 54K shares

President, R&D Crystal Adam sold 27K shares at $22.37/share ($603.9K); exercised options for 54K shares

xslF345X06/ownership.xml

xslF345X06/ownership.xmlSEC.gov

Graphics and non-inline formats (not embedded below).